Large PharmaUSMRKAggressive Acquisition Appetite
Merck Deal History & Licensing Activity
Merck is a large pharma headquartered in US. Over the past three years, Merck has been involved in 46 licensing and acquisition transactions, with a primary focus on Antibodies (9 deals). The company currently has 50 active clinical trials, primarily in Oncology.
Deals (12mo)
10
Active Trials
50
Top Modality
Antibodies
Focus Area
Oncology
Merck Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Merck in the past 12 months.
| Asset |
|---|